Data / Form D filings / MOLECULARMD CORP.
MOLECULARMD CORP.: Form D filings
MOLECULARMD CORP., a biotechnology company in Portland, OR, filed 5 Form D notices with the SEC between 2012 and 2017. The latest, on February 10, 2017, reports $2.1 million sold of a $2.1 million offering to 7 investors.
Find out what MOLECULARMD CORP. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1341 SW CUSTER DRIVE, Portland, OR, 97219
- Phone
- (503) 459-4974
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1542181
The full lists. Form D filings in Oregon: 434 rows, $21.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 10, 2017 | New notice | $2,070,300 | $2,070,300 | $0 | 7 | Jan 31, 2017 | sec.gov |
| Jul 18, 2016 | New notice | $2,000,000 | $500,000 | $1,500,000 | 6 | Jul 5, 2016 | sec.gov |
| May 20, 2013 | New notice | $2,500,000 | $2,500,000 | $0 | 4 | May 3, 2013 | sec.gov |
| Apr 5, 2012 | Amendment | $9,000,000 | $8,000,000 | $1,000,000 | 6 | Feb 3, 2012 | sec.gov |
| Feb 15, 2012 | New notice | $8,000,000 | $8,000,000 | $0 | 4 | Feb 3, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Chad G. Galderisi | Executive Officer | |
| Sheridan D. Snyder | Executive Officer, Director | |
| Sheridan G. Snyder | Director | |
| Matthew G. Rice | Director | |
| Frederick G. Eibel | Executive Officer | |
| Ryan G. Dunlap | Executive Officer | |
| Peter G. Maag | Director | |
| Cindy G. Spittle | Executive Officer | |
| Drew G. Graham | Director |
Other biotechnology companies in Oregon that filed recently
- UBIVAC, INC. $80,000 · Aug 27, 2026
- Trace Biosciences Inc. $8.3 million · Aug 12, 2026
Every Form D from the week of Feb 6, 2017 · All recent filings in Oregon · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MOLECULARMD CORP. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.